ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01540110
Recruitment Status : Active, not recruiting
First Posted : February 28, 2012
Last Update Posted : December 19, 2017
Sponsor:
Information provided by (Responsible Party):
National Cancer Centre, Singapore

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 2018
  Estimated Study Completion Date : August 2018